NuCana (NCNA) Common Equity (2015 - 2025)

NuCana (NCNA) reported Common Equity of $32.4 million for Q4 2025, up 323.44% on a YoY basis from $7.6 million in Q4 2024, and down 7.5% sequentially from $35.0 million in Q3 2025.

NuCana (NCNA) Common Equity (2015 - 2025) Analysis & Trends

NuCana (NCNA) has 11 years of Common Equity data on file, last reported at $32.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 323.44% year-over-year to $32.4 million; the trailing twelve-month figure through Dec 2025 stood at $32.4 million (up 323.44% YoY), and the FY2025 full-year result was $32.1 million, up 321.44% from the prior year.
  • Common Equity slipped to $32.4 million in Q4 2025, from $35.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $126.1 million in Q1 2021 to a low of $4.8 million in Q2 2024.
  • A 5-year average of $46.4 million and a median of $34.6 million in 2023 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity plunged 86.0% in 2024 and soared 519.25% in 2025, its largest moves.
  • Tracing NCNA's Common Equity over 5 years: stood at $88.4 million in 2021, then sank by 48.89% to $45.2 million in 2022, then plunged by 59.09% to $18.5 million in 2023, then tumbled by 58.64% to $7.6 million in 2024, then surged by 323.44% to $32.4 million in 2025.
  • Business Quant data shows NCNA's Common Equity at $32.4 million in Q4 2025, $35.0 million in Q3 2025, and $9.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 251.12 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -98.34 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.76 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.36 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 19.36 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 31.42 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 795.79 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.50 Bn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 1.08 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 32.36 Mn
Sep 30, 2025 34.98 Mn
Jun 30, 2025 9.85 Mn
Mar 31, 2025 5.26 Mn
Dec 31, 2024 7.64 Mn
Sep 30, 2024 5.65 Mn
Jun 30, 2024 4.80 Mn
Mar 31, 2024 12.85 Mn
Dec 31, 2023 18.48 Mn
Sep 30, 2023 27.58 Mn
Jun 30, 2023 34.26 Mn
Mar 31, 2023 38.59 Mn
Dec 31, 2022 45.16 Mn
Sep 30, 2022 62.10 Mn
Jun 30, 2022 70.57 Mn
Mar 31, 2022 78.79 Mn
Dec 31, 2021 88.36 Mn
Sep 30, 2021 106.77 Mn
Jun 30, 2021 117.68 Mn
Mar 31, 2021 126.11 Mn